Pharmaceutical Business Intelligence

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 7,429,602

« Back to Dashboard

Summary for Patent: 7,429,602

Title:Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva
Abstract:Treating allergic conjunctivitis by administered aqueous solutions containing epinastine, optionally in the form of its racemate or its enantiomers and optionally, in the form of the pharmacologically acceptable acid addition salts thereof, to the conjunctiva.
Inventor(s): Trach; Volker (Biberach, DE), Duschler; Gerold (Ehingen, DE)
Assignee: Boehringer Ingelheim Pharma GmbH & Co. Kg (Ingelheim, DE)
Application Number:11/863,008
Patent Claim Types:
see list of patent claims
Use; Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: 7,429,602

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 54 516Nov 12, 1999

International Patent Family for Patent: 7,429,602

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine74563► Subscribe
TaiwanI225401► Subscribe
Turkey200201270► Subscribe
Slovakia287343► Subscribe
Slovakia8302002► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.